Plasma Epstein-Barr virus DNA level strongly predicts survival in metastatic/recurrent nasopharyngeal carcinoma treated with palliative chemotherapy
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.25932/fullpdf
Reference26 articles.
1. Cancer in Asia-incidence rates based on data in cancer incidence in 5 continents IX (1998-2002);Shin;Asian Pac J Cancer Prev.,2010
2. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival;Lin;J Clin Oncol.,2003
3. Changing epidemiology of nasopharyngeal carcinoma in Hong Kong over a 20-year period (1980-99): an encouraging reduction in both incidence and mortality;Lee;Int J Cancer.,2003
4. Update on the management and therapeutic monitoring of advanced nasopharyngeal cancer;Loong;Hematol Oncol Clin North Am.,2008
5. Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: current and future directions;Ma;Cancer Sci.,2008
Cited by 132 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The efficacy of adjuvant chemotherapy in patients with different midpoint-radiotherapy Epstein-Barr virus DNA plasma loads;Oral Oncology;2024-09
2. Small extracellular vesicle CA1 as a promising diagnostic biomarker for nasopharyngeal carcinoma;International Journal of Biological Macromolecules;2024-08
3. Radiomic signatures associated with tumor immune heterogeneity predict survival in locally recurrent nasopharyngeal carcinoma;JNCI: Journal of the National Cancer Institute;2024-04-19
4. Salvage endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma in a non-endemic area;European Archives of Oto-Rhino-Laryngology;2024-03-14
5. AI-Based Risk Score from Tumour-Infiltrating Lymphocyte Predicts Locoregional-Free Survival in Nasopharyngeal Carcinoma;Cancers;2023-12-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3